Discovery of covalent ligands on the proteome-wide scale | Chemical & Engineering News
Volume 94 Issue 25 | p. 8 | Concentrates
Issue Date: June 20, 2016

Discovery of covalent ligands on the proteome-wide scale

Fragments bind to proteins previously thought undruggable
Department: Science & Technology
News Channels: Biological SCENE, Analytical SCENE
Keywords: proteomics, fragment-based drug discovery

There may be an untapped reservoir of “druggable” protein targets, according to a new study. To help find potential drug targets, Benjamin F. Cravatt, Keriann M. Backus, and coworkers at Scripps Research Institute in La Jolla, Calif., have extended a method called fragment-based ligand discovery to a proteome-wide scale in native biological systems and used it to identify many proteins that weren’t previously known to bind ligands (Nature 2016, DOI: 10.1038/nature18002). The researchers exposed intact cells or cell lysates to protein-binding molecular fragments attached to electrophilic groups that covalently react with cysteine. Then they treated the proteins with an alkyne-labeled probe known to react with many cysteines in the proteome. If a fragment is already bound to a cysteine, that cysteine is described as “liganded,” and the fragment blocks the probe from binding. In 637 proteins, the researchers identified 758 liganded cysteines, which they defined as ones for which probe binding was reduced by at least 75% relative to samples exposed to dimethyl sulfoxide (DMSO) instead of the fragments. More than 85% of the proteins thus identified were previously not known to bind ligands. For example, the researchers identified ligands that target and distinguish between the inactive precursor forms of two caspases, a family of enzymes that are involved in cell death.

[+]Enlarge
Target discovery
Cells or cell lysates are treated with cysteine-reactive fragment electrophiles or DMSO (reference samples), followed by an alkyne-labeled cysteine-reactive probe. Click chemistry is used to add isotope-labeled biotin tags to the alkyne-labeled probes—heavy isotope tags for the DMSO-treated samples and light ones for the fragment-treated samples. Both samples are combined, digested, and analyzed by liquid chromatography and mass spectrometry.
Credit: adapted from Nature
Scheme showing method for screening proteins with cysteine-reactive fragment molecules.
 
Target discovery
Cells or cell lysates are treated with cysteine-reactive fragment electrophiles or DMSO (reference samples), followed by an alkyne-labeled cysteine-reactive probe. Click chemistry is used to add isotope-labeled biotin tags to the alkyne-labeled probes—heavy isotope tags for the DMSO-treated samples and light ones for the fragment-treated samples. Both samples are combined, digested, and analyzed by liquid chromatography and mass spectrometry.
Credit: adapted from Nature
 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment